Spatial Biology US EAST

Hyatt Regency BostonLink

NanoString is thrilled to be heading to Boston as the Diamond Sponsor of Spatial Biology US East June 10-11! During the conference we have a number of exciting activities to highlight how GeoMx DSP and CosMx SMI are pushing the boundaries of spatial biology insights.

Bringing together over 350+ thought leaders in the explosive field of spatial biology, Oxford Global’s 3rd Annual Spatial Biology US East Coast Congress is the place to learn more about exciting developments in spatial technologies, and how developers are working together to get them into the hands of clinicians for use in real- world settings.

Benefits of attending:

  • Discuss the latest innovations in emerging multi-omics techniques.
  • Discover how spatial biology is making an impact within the pharmaceutical industry.
  • Discuss potential applications from the acceleration of drug development to investigative toxicology and optimising pipeline alignment.
  • Gain insights into the integration of multi-omics datasets.
  • Join a series of workshops, roundtables, and panel discussions. Interactive session topics will include: Overcoming The Challenges Of Spatial Data Integration, Moving Towards Clinical Trial Phases To Support Disease Diagnostics, Applications Of Spatial Proteomics, & Intersection Of Digital Pathology & Spatial Biology
4:25 Ultra-High-Plex Multiomic high throughput and flexible Spatial Biology EcosystemAnkush Tyagi, NanoString
4:45 Spatial transcriptomic profiling of non-small cell lung cancer to discover novel drivers of tumor-mediated immune evasionChristina Cho, Yale Medicine School
5:05Spatial solutions for clinical biopsy samplesKirsty MacLean, Neogenomics
5:25Industry Panel Discussion Moderator: Espy Anguiano
Panelists: Kirsty MacLean, NeoGenomics ​
Alex M. Tamburino, Merck,
Christina Cho, Yale​
Aniruddh Solanki, Canopy


Patrick Danaher, PhD

Principal Biostatistician, NanoString

Christina Cho, PhD

Associate Research Scientist, Yale School of Medicine

Kirsteen Maclean, PhD

Principal Scientist, NeoGenomics Laboratories

Kirsty has 20 years of leadership experience addressing academic, clinical, biotechnology, clinical research organizations (CRO) and pharmaceutical industries through clinical/technical communication, sales support, and market intelligence. Kirsty is currently a Principal Scientist under Pharma Services at NeoGenomics supporting all aspects of the spatial biology workflow. She holds a PhD in Hematology from University College London and a BS (Hons) in Biochemistry from Glasgow Caledonian University.

Ankush Tyagi, MS

Field Application Scientist, NanoString

Espy Anguiano, PhD, MS-MBA

Scientific Market Development Director for Biopharma, NanoString

Dr. Espy Anguiano, Scientific Market Development Director at NanoString, obtained her PhD in Biomedical Science from Baylor University and holds a dual MBA degree from Temple University. She has over 20 years of experience in translational and clinical biomarker research in both academic and industry settings. Dr. Anguiano is a biomarker technology subject matter expert and has led biomarker and biomarker technology strategies for many early- and late-phase clinical trials in oncology and non-oncology disease areas. In her current role at NanoString, she is responsible for enabling the successful adoption of bulk and spatial technologies in research activities supporting drug discovery and development.